UBS (UBS)
(Delayed Data from NYSE)
$29.02 USD
+0.49 (1.72%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $29.02 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.02 USD
+0.49 (1.72%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $29.02 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Is Banco Santander (SAN) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UBS or HDB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UBS vs. HDB: Which Stock Is the Better Value Option?
Federated (FHI) Q1 Earnings Miss Estimates, AUM Increases
by Zacks Equity Research
Reduced net investment advisory fees and net service fees hurt Federated's (FHI) Q1 results. Nonetheless, controlled operating expenses and an improved AUM are positives.
Webster (WBS) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Higher revenues and a solid balance sheet position drive the Q1 results of Webster Financial (WBS). However, lower NIM and deteriorating credit quality are downsides.
BOK Financial (BOKF) Q1 Earnings & Revenues Miss, Loans Rise
by Zacks Equity Research
Lower revenues and decline in deposits balance undermine BOK Financial's (BOKF) Q1 results against tailwinds like lower expenses and improved credit quality.
Evercore (EVR) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Impressive revenue growth and rise in AUM aid Evercore's (EVR) Q1 results. Escalating expenses ail.
UBS' (UBS) Q1 Earnings Impress on Higher Operating Income
by Zacks Equity Research
Increase in net interest income and strong capital position support UBS Group's (UBS) Q1 earnings against offsetting factors like increased expenses and net credit loss expenses.
UBS (UBS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
UBS (UBS) delivered earnings and revenue surprises of 17.31% and 4.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ICICI Bank's (IBN) Q4 Earnings Improve on Rising Loan Demand
by Zacks Equity Research
A solid rise in retail loan demand, higher net interest income and non-interest income and a fall in provisions aid ICICI Bank's (IBN) fiscal Q4 results.
UBS Group (UBS) Gears Up for Q1 Earnings: What to Expect?
by Zacks Equity Research
UBS Group (UBS) Q1 results are expected to mirror lower performance fees in asset management, while investment banking is likely to have taken a hit from subdued capital markets and equity issuance.
UBS (UBS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UBS (UBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
United Bancorporation (UBAB) Announces New Share Buyback Plan
by Zacks Equity Research
United Bancorporation (UBAB) announces a new stock repurchase program of up to 188,298 shares, representing 5% of the current outstanding shares of its common stock.
UBS Announces a New Share Repurchase Program of Up to $6B
by Zacks Equity Research
UBS announces a new share repurchase program for 2022 of up to $6 billion of common stock, valid for two years.
Trustmark (TRMK) Enters Deal to Sell Corporate Trust Business
by Zacks Equity Research
Trustmark (TRMK) agrees to sell its corporate trust business to The Peoples Bank, the subsidiary of Peoples Financial.
Strength Seen in Western New England Bancorp (WNEB): Can Its 7.8% Jump Turn into More Strength?
by Zacks Equity Research
Western New England Bancorp (WNEB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UBS Group (UBS), Mitsubishi to Sell Japanese Realty JV to KKR
by Zacks Equity Research
UBS Group (UBS) and Mitsubishi announce the divestiture of their Japanese real estate joint venture to KKR for $2 billion. The deal is set to increase Common Equity Tier 1 capital ratio.
Should Value Investors Buy These Finance Stocks?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Deutsche Bank (DB) Limits Exposure in Russia and Ukraine
by Zacks Equity Research
Deutsche Bank (DB) limits its exposure to Russia and Ukraine to avoid major impacts to its financials.
Should Investors Fret Over UBS Group's (UBS) Russian Exposure?
by Zacks Equity Research
UBS Group (UBS) reveals its $634-million exposure to Russia that has subsided since 2021 end.
UBS (UBS) Surges 6.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
UBS (UBS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UBS vs. CM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UBS vs. CM: Which Stock Is the Better Value Option?
Franklin (BEN) Rides on Strategic Buyouts, Higher Costs Ail
by Zacks Equity Research
Franklin's (BEN) efforts to expand via acquisitions and strong diversification strategies are commendable. Yet, higher expenses and a strict regulatory environment are major drags.
Why Is UBS (UBS) Down 14.7% Since Last Earnings Report?
by Zacks Equity Research
UBS (UBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Investors Fret Over Citi's (C) $9.8B Russian Exposure?
by Zacks Equity Research
Given its strong fundamentals, Citi's (C) disclosure of its approximate $10-billion exposure to Russia is not likely to affect its financials.
UBS Group (UBS) to Spruce Up Wealth Unit for the Affluent
by Zacks Equity Research
UBS Group (UBS) will create a new business unit to serve the super-rich by bringing together several services catering to the elite demographic.